Novavax Is 96% Effective Against COVID-19, Says Company by OB Bureau 5 years ago New Delhi: US-based biotech company Novavax’s COVID-19 vaccine was 96.4 per cent effective against the original strain of the virus in a phase-3 trial in the UK, the company has ...